AvKARE

20 FDA drug recalls on record — 1 Class I.

Date	Class	Drug	Status
2026-02-13	Class II	Amantadine Hcl	Ongoing
2025-12-31	Class II	Rosuvastatin	Ongoing
2025-09-02	Class II	Norgestimate And Ethinyl Estradiol	Ongoing
2025-08-25	Class II	Chlorpromazine Hydrochloride	Ongoing
2025-08-25	Class II	Chlorpromazine Hydrochloride	Ongoing
2025-06-26	Class III	Pitavastatin	Ongoing
2025-06-26	Class III	Pitavastatin	Ongoing
2025-05-13	Class II	Celecoxib	Ongoing
2025-05-09	Class II	Chlorthalidone	Ongoing
2025-02-04	Class II	Silodosin	Ongoing
2025-01-21	Class II	Irbesartan	Ongoing
2024-12-18	Class III	Polyvinyl Alcohol	Ongoing
2024-12-18	Class III	Carboxymethylcellulose Sodium	Ongoing
2024-12-04	Class II	Nitrofurantoin Capsules, USP, 100 mg, 50 Capsules (5 x 10) Unit Dose per carton, Rx Only,	Ongoing
2024-11-27	Class II	Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN	Ongoing
2024-11-27	Class II	Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN	Ongoing
2024-11-27	Class II	Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE, Pulaski, TN	Ongoing
2024-10-18	Class II	Sunitinib Malate	Ongoing
2024-10-18	Class II	Sunitinib Malate	Ongoing
2024-03-28	Class I	Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only,	Terminated